Cetera Investment Advisers
AMRX icon

Cetera Investment Advisers’s Amneal Pharmaceuticals AMRX Stock Holding History

Cetera Investment Advisers’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$705K Buy
40,744
+12,862
+46% +$176K ﹤0.01% 3371
2026
Q1 		$347K Buy
27,882
+6,437
+30% +$86.4K ﹤0.01% 3851
2025
Q4 		$270K Buy
21,445
+6,875
+47% +$78.7K ﹤0.01% 3996
2025
Q3 		$146K Buy
+14,570
New +$131K ﹤0.01% 4242

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Cetera Investment Advisers's AMRX Position: Q2 2026 in Review

Cetera Investment Advisers increased its Amneal Pharmaceuticals (AMRX) stake by 46% in Q2 2026, buying an estimated $176K and bringing the position to 40,744 shares worth $705K. The position accounts for ﹤0.01% of the portfolio, ranked #3371.

Cetera Investment Advisers first reported a position in AMRX in Q3 2025 and has held it in 4 quarters since. 310 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Cetera Investment Advisers held 40,744 shares of Amneal Pharmaceuticals worth $705K as of Q2 2026.
  • Cetera Investment Advisers bought 12,862 Amneal Pharmaceuticals shares in Q2 2026, an estimated $176K.
  • Amneal Pharmaceuticals made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #3371 holding.
  • Cetera Investment Advisers first reported a position in Amneal Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 310 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.